Skip to Content
Print Share

Medications for Breast Cancer, Metastatic

Other names: Metastatic Breast Cancer

What is Breast Cancer, Metastatic:  Metastatic breast cancer (Stage IV breast cancer) is an advanced form of breast cancer that occurs when breast cancer cells spread from the breast into surrounding tissue and distant organs.

Medications to treat Breast Cancer, Metastatic

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
paclitaxel Rx D N 3 reviews
8.0

Generic name: paclitaxel systemic

Brand names:  Taxol, Onxol

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
eribulin Rx D N 8 reviews
9.0

Generic name: eribulin systemic

Brand name:  Halaven

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
lapatinib Rx D N 1 review
10

Generic name: lapatinib systemic

Brand name:  Tykerb

Drug class: EGFR inhibitors, HER2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Docefrez Rx D N Add review Add

Generic name: docetaxel systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
palbociclib Rx N 24 reviews
6.0

Generic name: palbociclib systemic

Brand name:  Ibrance

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
ado-trastuzumab emtansine Rx D N Add review Add

Generic name: ado-trastuzumab emtansine systemic

Brand name:  Kadcyla

Drug class: HER2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Onxol Rx D N Add review Add

Generic name: paclitaxel systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
bevacizumab Off Label Rx C N 3 reviews
9.0

Generic name: bevacizumab systemic

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

Off Label: Yes

 
paclitaxel protein-bound Rx D N 1 review Add

Generic name: paclitaxel protein-bound systemic

Brand name:  Abraxane

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

 
ixabepilone Rx D N Add review Add

Generic name: ixabepilone systemic

Brand name:  Ixempra

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Kadcyla Rx D N Add review Add

Generic name: ado-trastuzumab emtansine systemic

Drug class: HER2 inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
toremifene Rx D N Add review Add

Generic name: toremifene systemic

Brand name:  Fareston

Drug class: hormones/antineoplastics, selective estrogen receptor modulators

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Kisqali Rx U Add review Add

Generic name: ribociclib systemic

Drug class: multikinase inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
ribociclib Rx U Add review Add

Generic name: ribociclib systemic

Brand name:  Kisqali

Drug class: multikinase inhibitors

For consumers: interactions, side effects

For professionals: AHFS DI Monograph

 
Page 1 2 Next

Learn more about Breast Cancer, Metastatic

Micromedex® Care Notes

Symptom checker

Drugs.com Health Center

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Drugs.com Mobile Apps

The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

Explore Apps
Hide